2011 Digestive Disease Week: UNC Research Highlights
5/10/2011
Digestive Disease Week (DDW) is the largest international gathering of physicians, researchers and academics in the fields of gastroenterology, hepatology, endoscopy and gastrointestinal surgery...
Open-Access Colonoscopy Found To Be Safe
5/10/2011
Nurse-driven, open-access colonoscopy programs are as effective and safe as colonoscopy following a consultation with a gastroenterologist, according to researchers at Henry Ford Hospital. "Our results showed no significant differences in safety outcomes related to perforation rate, emergent surgery, post-polypectomy bleed, overall lower gastrointestinal bleed, or death," says Gregory Olds, M...
Research being presented at Digestive Disease Week® (DDW) shows that psychological issues may play a role in the severity of gastrointestinal symptoms. Another study found that just an hour a week of low-intensity exercise decreases the risk for colon polyps, particularly among overweight and obese individuals...
Blood Test For Colon Cancer Screening Beneficial For Some Seniors, But Not For Many Others
5/10/2011
A new study of U.S. veterans ages 70 and older finds that the healthiest get the most benefit from current colon cancer screening methods. However, for many less healthy veterans the burdens of screening may outweigh the benefits...
Screening Colonoscopies Done More Often Than Recommended On Medicare Beneficiaries
5/09/2011
A significant number of screening colonoscopies are being carried out more often than the recommended intervals, while older individuals treated at Veteran Affairs centers, where positive fecal blood tests merited follow-up colonoscopies, were not getting them, or they caused problems when colonoscopies were performed, researchers from the University of Texas wrote in Archives ...
Inovio Pharmaceuticals, Inc. (NYSE Amex: INO), a leader in the development of therapeutic and preventive vaccines against cancers and infectious diseases, has reported data demonstrating long-term durability of immune responses induced by VGX-3100, its investigational DNA vaccine for treating cervical dysplasia and cancer caused by human papillomavirus (HPV)...
Cutting-Edge Research Presented During Digestive Disease Week
5/08/2011
Clinicians, researchers and scientists from around the world gathered for Digestive Disease Week® (DDW) 2011, the largest and most prestigious gastroenterology meeting, from May 7-10, 2011, at McCormick Place, Chicago, IL...
Epigenomics AG (Frankfurt Prime Standard: ECX), the cancer molecular diagnosis company, today announced the signing of a supply agreement with Life Technologies Corporation, a global provider of innovative life science solutions. As the Original Equipment Manufacturer (OEM) Life Technologies will supply its Dynabeads® MyOne™ SILANE and buffers for Epigenomics' Epi proColon® 2...
ONCO-101 May Prove Effective Against Ovarian And Endometrial Cancer
5/05/2011
The Translational Genomics Research Institute (TGen) has licensed its first drug, a unique compound that targets cancer tumors by modifying the actions of proteins. This announcement is another key fulfillment of TGen's primary mission: To move laboratory discoveries more rapidly into therapeutics that can immediately help patients improve their quality of life...
Racial Disparities Still Exist In Colorectal Cancer Screening Despite Increased Medicare Coverage
5/05/2011
Despite expanded Medicare coverage for colorectal cancer screening tests, lower rates still exist among blacks and Hispanics compared to other ethnic groups, according to research published in Cancer, Epidemiology, Biomarkers & Prevention, a journal of the American Association for Cancer Research...